Harkin Exit Intensifies Industry Need To Bolster Supplement Caucus
This article was originally published in The Tan Sheet
One of DSHEA’s chief authors, Tom Harkin will retire from the Senate after 2014, pressuring supplement industry leaders to identify the next generation of congressional supporters. CRN’s Steve Mister says it will not be possible to replace the duo of Harkin and Orrin Hatch, who is retiring after 2018.
You may also be interested in...
Sen. Hatch on path to re-election; Senate passes FDA Safety and Innovation Act; DSM petitions FDA for folic acid fortification of masa flour; Nutrition 21 returns under new management; ZO Skin Health defends trademarks; more news In Brief.
Trade groups say FDA committed to revisiting issues in the NDI draft guidance including how firms prove ingredients’ grandfathered status, notifications required for ingredients or finished products and data necessary to demonstrate NDI safety. The agency’s decision followed a meeting between industry allies Sens. Hatch and Harkin and FDA Commissioner Hamburg.
Sens. Orrin Hatch and Tom Harkin are no strangers to dietary supplement firms as longtime champions for their interests, but for the first time they are members of the industry's congressional caucus.